Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $2.29M | $3.29M | $1.98M | $0.00 | $22.0K |
| Revenue growth | — | 43.4% | -39.8% | -100.0% | — |
| Operating income | -$40.4M | -$62.1M | -$92.7M | -$61.0M | -$68.8M |
| Operating margin | -1765.4% | -1889.3% | -4687.9% | — | -312631.8% |
| Net income | -$55.3M | -$58.2M | -$71.1M | -$52.8M | -$61.4M |
| Net margin | -2414.6% | -1771.5% | -3592.4% | — | -279263.6% |
| EPS (diluted) | -$19.00 | -$2.23 | -$16.01 | -$12.03 | -$2.73 |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | -$34.6M | -$34.9M | -$52.4M | -$41.4M | -$43.4M |
| Capital expenditures | $5.54M | $41.4M | $12.0M | $26.0K | $196K |
| Free cash flow | -$40.2M | -$76.3M | -$64.4M | -$41.4M | -$43.6M |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $56.0M | $57.6M | $35.9M | $48.3M | $16.4M |
| Total assets | $96.7M | $181M | $119M | $97.8M | $51.2M |
| Total liabilities | $36.3M | $53.5M | $52.6M | $47.1M | $45.6M |
| Shareholders' equity | -$111M | $127M | $66.9M | $25.6M | $5.59M |
| Retained earnings | -$115M | -$173M | -$244M | -$297M | -$359M |
| Shares (wtd avg diluted) | 2.91M | 26.1M | 4.44M | 4.60M | 22.5M |
Every figure is extracted from Senti Biosciences Holdings, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.